Advertisement
| dual antiplatelet therapy after pci guidelines: Primary Angioplasty Timothy J Watson, Paul JL Ong, James E Tcheng, 2018-07-13 This book is open access under a CC BY 4.0 license. This quick-reference handbook offers a concise and practical review of key aspects of the treatment of ST-segment elevation myocardial infarction (STEMI) in the era of primary percutaneous coronary intervention (PPCI). In the context of STEMI, PPCI is the preferred mode of emergency revascularization. Access to PPCI is rapidly increasing and is now routinely practiced in both general and specialist hospitals and there has been a recent emphasis on developing STEMI networks to enhance and expedite the referral pathway. This coupled with concurrent developments to enhance the safety and efficacy of the PPCI procedure has heralded an era where STEMI interventions are increasingly considered an important subspecialty within interventional cardiology. Written by leading cardiologists who have been instrumental in the adoption of PPCI in their respective institutions, the book provides junior and senior cardiologists alike with insightful and thought-provoking tips and tricks to enhance the success of PPCI procedures, which may in turn translate into direct improvements in outcomes. The book is also relevant for healthcare providers and emergency department physicians. |
| dual antiplatelet therapy after pci guidelines: Bioresorbable Scaffolds Yoshinobu Onuma, Patrick W.J.C. Serruys, 2017-10-02 This book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic stent. The book provides an overview of the technology including non-clinical studies and clinical evidences in order to help clinicians understand the appropriate application of the technology and the optimal techniques of implantation. It covers the basics of bioresorbable scaffolds; bench test results; preclinical studies; clinical evidences; and tips and tricks of implantation. |
| dual antiplatelet therapy after pci guidelines: Antithrombotic Therapy Richard C. Becker, Dan J. Fintel, David Green, 2010-12-31 Clinical application of antithrombotic therapy in both arterial disease (acute coronary syndromes, acute MI, peripheral arterial disease, valvular heart disease, atrial fibrillation) and venous disease, (venous thromboembolic disease and pulmonary embolism). Results of major clinical trials and their implications for clinical practice. |
| dual antiplatelet therapy after pci guidelines: Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease Sorin Brener, 2021-01-26 Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to understand platelet physiology and its relevance to ischemic events. Data on shorter than usual duration of DAPT, and on extended therapy beyond the recommendation of current guidelines is presented in great detail, summarizing a large body of evidence into concrete, relevant recommendation that is readily adaptable by practicing clinicians. A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years. Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians Explores the current status of DAPT, controversial topics, and future developments and trends in this field Edited and contributed by renowned cardiologists in the field |
| dual antiplatelet therapy after pci guidelines: Practical Manual of Interventional Cardiology Annapoorna Kini, Samin Sharma, Jagat Narula, 2014-11-26 This practical handbook is based on an internal working manual developed by staff and fellows at Mount Sinai Heart Cardiovascular Catheterization Laboratory, renowned for its high-volume and low complication complex coronary procedures. The Practical Handbook of Interventional Cardiology captures the knowledge and methodological know-how from leaders in interventional cardiology, it intends to guide users in a stepwise, methodical and practical approach through various cardiac interventional procedures in order to achieve maximum patient safety and improved outcomes. From patient selection, preoperative work-up, setting up equipment to step-by-step illustrations of various procedural details and troubleshooting, this handbook captures all the details necessary to perform the simplest to the most complex cardiac interventions. The book is designed for cardiologists and trainees who desire an efficient way to review the steps of various cardiac interventional procedures and a quick, reliable reference for everyday use. |
| dual antiplatelet therapy after pci guidelines: Antiplatelet Therapy in Cardiovascular Disease Ron Waksman, Paul A. Gurbel, Michael A. Gaglia, Jr., 2014-03-24 Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents. This important new book: Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects. Written by an international “who’s who” of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists. |
| dual antiplatelet therapy after pci guidelines: Antiplatelet and Anticoagulation Therapy Albert Ferro, David A. Garcia, 2012-10-13 This title will be presented as highly practical information pn pharmaceutical antiplatelet and anticoagulation therapy, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series. Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas. |
| dual antiplatelet therapy after pci guidelines: Interventional Cardiology George D. Dangas, Carlo Di Mario, Nicholas N. Kipshidze, Peter Barlis, Tayo Addo, 2016-11-28 Expert guidance from internationally recognized authorities, who provide clear and current updates on all aspects of interventional cardiology. This new edition; Contains a radically expanded chapter contents list presented in four clear sections; coronary interventions, interventional pharmacology, structural heart interventions, and endovascular therapy Includes 46 new chapters, including the latest advances in bioresorbable coronary stents, advanced transcatheter aortic valve replacement, MitraClip, new transcatheter mitral valve interventions, and more Chapters are templated for rapid referral, beginning with pathophysiological background and relevant pathology, moving to mechanisms of treatment, device description, procedural techniques, follow-up care, and ending with risks, contraindications and complications Multiple choice questions at the end of each chapter for self-assessment, a total of more than 400 MCQs in the book Features 19 procedural videos, hosted on a companion website |
| dual antiplatelet therapy after pci guidelines: The Anesthesia Guide Arthur Atchabahian, Ruchir Gupta, 2013-01-05 A PRACTICAL QUICK-REFERENCE GUIDE TO CLINICAL ANESTHESIOLOGY--PERFECT FOR THE OR AND ICU This carry-anywhere handbook is concise yet comprehensive, adeptly covering the wide range of topics encountered in the practice of anesthesiology. It is the perfect learning tool for trainees and an outstanding reference for experienced anesthesiologists. Presented in full color, The Anesthesia Guide utilizes numerous illustrations, diagrams, tables, and algorithms to impart must-know information on how specific cases should be managed. Coverage includes drug dosages, monitoring, complications, and clinical pearls. An international team of contributors ensures coverage of topics from a global perspective. The Anesthesia Guide is divided into thirteen color-coded sections for ease of reference: Preoperative Coexisting Disease Monitoring General Anesthesia Specific Procedures Cardiovascular and Thoracic Neuro Regional Acute Pain Pediatrics Obstetrics Critical Care Rapid Reference (includes important formulae, commonly used phrases in anesthesiology, BLS, ACLS, PALS, and management of malignant hyperthermia) |
| dual antiplatelet therapy after pci guidelines: Drug-Coated Balloons Bernardo Cortese, 2019-06-19 This book provides a comprehensive, up-to-date summary of drug-coated balloon (DCB) technology and the role of DCBs in the treatment of coronary and peripheral arterial disease. In addition to clear explanation of how DCBs works, readers will find an enlightening analysis of the mistakes and successes of the past decade and the emergence of the latest delivery systems, which combine a more deliverable device with much improved drug delivery to the vessel wall. The full range of current applications of DCBs are reviewed in detail, drawing on the latest scientific evidence. Due attention is paid to newer devices, with provision of technical insights and documentation of the available clinical data. Ongoing research projects, remaining technical challenges, likely future directions, and reimbursement issues are also carefully considered. This book will be a useful tool for any interventional cardiologist, interventional radiologist, or vascular surgeon who wishes to acquire a deep knowledge of this technology and its application in both coronary and peripheral interventions. |
| dual antiplatelet therapy after pci guidelines: Percutaneous Revascularization Techniques Manuel Maynar-Moliner, 1993 |
| dual antiplatelet therapy after pci guidelines: Network Meta-analysis Giuseppe Biondi-Zoccai, 2014 Network meta-analyses and mixed treatment comparisons represent the uppermost level in the evidence hierarchy for decision making, in medicine as well as in other scholarly fields. This book covers the main topics which should be mastered to critically read and interpret as well as, if deemed worthwhile, perform and report independently a network meta-analysis and mixed treatment comparison. The text includes dozens of tables and illustrations to guide visually the reader in understanding the basics as well as the more refined details of network meta-analyses. |
| dual antiplatelet therapy after pci guidelines: Anticoagulation Therapy Joe F. Lau, Geoffrey D. Barnes, Michael B. Streiff, 2018-04-16 This book presents the latest evidence and guidelines supporting the use of anticoagulant therapy for various clinical scenarios. The field of anticoagulation therapy is evolving rapidly, particularly since the arrival and widespread adoption of direct oral anticoagulants. Organized in two parts, this book reviews the pharmacologic properties of various anticoagulants and details the clinical applications of anticoagulant therapy. Drugs such as warfarin and unfractionated heparin, as well as parenteral and direct oral anticoagulants are discussed in terms of their pharmacokinetics, drug-disease interactions, dosing strategies, and risk considerations. Clinical applications of anticoagulant therapy in disorders such as acute coronary syndromes, atrial fibrillation, and thrombophilia and in special populations such as pregnant women, the elderly, and in the patient with cancer are highlighted. Clinical vignettes, algorithms, clinical pearls, and self-assessment questions are integrated throughout the book. Featuring contributions from authorities in the field, Anticoagulation Therapy is an essential resource for cardiologists, vascular medicine specialists, hematologists, internists, and all other healthcare professionals who prescribe anticoagulants. |
| dual antiplatelet therapy after pci guidelines: ASPC Manual of Preventive Cardiology Ezra A. Amsterdam, Nathan Wong, Ezra Amsterdam, MD, Roger Blumenthal, MD, FACC, FAHA, 2014-10-23 Endorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise descriptions of each major cardiovascular risk factor, and practical, to-the-point discussions of current best practices in clinical management. In addition, the Manual includes chapters on peripheral arterial disease, stroke, smoking, contemporary cardiovascular imaging, heart failure, metabolic syndrome, thrombosis, nutrition, special populations, novel risk factors, and psychosocial stress. Throughout the Manual, recommendations are based on the most recent prevention guidelines of the American College of Cardiology and American Heart Association, including those on Risk Assessment, Lifestyle Recommendations, Blood Cholesterol, and Obesity, as well as the new guidelines on Hypertension. Chapter authors are recognized leaders in each area of practice, and special efforts have been made by the authors and editors to ensure that the content of all chapters is as up-to-date as possible. Key Features: Presents a highly practical focus on the application of current guidelines and practice standards regarding cardiovascular risk factors Recommendations based on the most recent prevention guidelines Authored by recognized leaders in the field Covers all major cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations |
| dual antiplatelet therapy after pci guidelines: Acute Heart Failure Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph E. Parrillo, 2009-12-24 For many years, there has been a great deal of work done on chronic congestive heart failure while acute heart failure has been considered a difficult to handle and hopeless syndrome. However, in recent years acute heart failure has become a growing area of study and this is the first book to cover extensively the diagnosis and management of this complex condition. The book reflects the considerable amounts of new data reported and many new concepts which have been proposed in the last 3-4 years looking at the epidemiology, diagnostic and treatment of acute heart failure. |
| dual antiplatelet therapy after pci guidelines: Advances in Extra-corporeal Perfusion Therapies Michael S. Firstenberg, 2019-01-10 Extracorporeal membrane oxygenation (ECMO) has evolved into an exciting and valuable tool to assist in the management of patients experiencing cardiogenic shock, severe acute respiratory failure, or often a combination of both. While outcomes remain less than ideal, they continue to improve with team experience, better patient selection, and a growing understanding of the nuances of managing patients who require mechanical circulatory support. Patients requiring ECMO are often extremely sick and have complex problems - initiating therapy before the development of end-organ damage is critical. Without doubt, teamwork, guidelines, and protocols are cornerstone concepts for clinical and program success - all topics that are emphasized in this text. The goals of this text are to further outline topics that help address some of the key challenges providers face when considering and applying extracorporeal support therapies to the evolving spectrum of acutely ill patients. |
| dual antiplatelet therapy after pci guidelines: Cardiovascular Thrombus On Topaz, 2018-08-18 Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions provides a comprehensive, up-to-date presentation of the research and clinical practices as related to the contemporary aspects of the diagnosis and management of cardiovascular thrombosis. The formation, identification and management of cardiovascular thrombus is of paramount importance for researchers and practicing physicians, yet it remains one of the most challenging diagnostic and clinical scenarios. This important reference connects between research, up-to-date clinical knowledge, and the technological tools available for diagnosis and management of thrombus in cardiovascular medicine. The book includes comprehensive descriptions and review of pathology, clinical presentations, diagnosis, pharmacotherapy, interventions and future trends. It is the perfect reference for basic science students and researchers in general and interventional cardiology, general and interventional radiology, vascular medicine specialists, and vascular, general and cardiac surgeons. Provides comprehensive presentation of the pathophysiology, clinical presentations and diagnosis of cardiovascular thrombosis Includes the most up-to-date information on the practical management of patients with thrombus related conditions Written by the leading experts in the field Describes the current and upcoming pharmacotherapy and technology available for thrombus research and treatment |
| dual antiplatelet therapy after pci guidelines: Models for Discrete Longitudinal Data Geert Molenberghs, Geert Verbeke, 2006-08-30 The linear mixed model has become the main parametric tool for the analysis of continuous longitudinal data, as the authors discussed in their 2000 book. Without putting too much emphasis on software, the book shows how the different approaches can be implemented within the SAS software package. The authors received the American Statistical Association's Excellence in Continuing Education Award based on short courses on longitudinal and incomplete data at the Joint Statistical Meetings of 2002 and 2004. |
| dual antiplatelet therapy after pci guidelines: Antiplatelet Therapy in ACS and A-Fib Victor L. Serebruany, Dan Atar, 2012 Written by top experts in the field Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better understanding of the pathogenesis of coronary heart disease and atrial fibrillation has led to refinements in antithrombotic strategies and clinical outcomes. With this in mind, some of the issues outlined in this book are new insights in genetic testing and modification of individualized antiplatelet therapy based on rapid bedside platelet analyzers. Most importantly, the current update of pros and cons of novel antiplatelet agents such as prasugrel and ticagrelor are provided in detail. Conventional antiplatelet strategies with aspirin and clopidogrel are also discussed. Special attention is devoted to experimental antiplatelet agents like PAR-1 thrombin receptor antagonists or aptamers. The ability to focus on different diseases beyond ACS, including heart failure and atrial fibrillation, distinguishes this publication. Each chapter was written by top experts in the field and scientists with the utmost authority and expertise to provide cardiologists, internists, and clinical pharmacologists with the latest updates. |
| dual antiplatelet therapy after pci guidelines: Pericardial Disease J. Soler-Soler, G. Permanyer, J. Sagristà-Sauleda, 2012-12-06 In November 1986, I was invited to attend a symposium held in Barcelona on Diseases of the Pericardium. The course was directed by Dr. J. Soler-Soler, director of Cardiology at Hospital General Vall d'Hebron in Barcelona. During my brief but delightful visit to this institution, my appreciation of the depth and breadth of study into pericardial diseases, carried out by Dr. Soler and his group, grew into the conviction that these clinical investigators have accumulated a wealth of information concerning pericardial diseases, and that investigators and clinicians practicing in English speaking countries would greatly profit from ready access to the results of the clinical investiga tions into pericardial disease carried out in Barcelona. The proceedings of the Barcelona conference were published in a beauti fully executed volume in the Spanish language edited by Dr. Soler and pro duced by Ediciones Doyma. Because I believe that this work should be brought to the attention of the English speaking scientific and clinical com munities, I encouraged Dr. Soler to have the book translated into English. I knew that this task could be accomplished and that the book would be trans lated into good English without change of its content. My confidence was based upon a translation of my own book, The Pericardium, into Spanish undertaken by Dr. Permanyer, who is a contributor and co-editor of the pre sent volume. |
| dual antiplatelet therapy after pci guidelines: Atrial Fibrillation and Percutaneous Coronary Intervention Andrea Rubboli, Gregory Y. H. Lip, 2016-11-30 This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs “bioactive”), the optimal regimen (e.g., triple therapy of OAC, aspirin, and clopidogrel vs the combination of OAC and a single antiplatelet agent), and the most suitable duration of the antithrombotic treatment prescribed at discharge (1 vs 6–12 months). The case-based management recommendations will be of wide practical value in the current health care context, where percutaneous coronary intervention is available even to patients with relevant co-morbidities, such as those warranting long-term OAC, and the indications for OAC are much broader than in the past. The book will appeal especially to clinical and interventional cardiologists, internal medicine specialists, hematologists, and family physicians and will also be of interest to cardiology and internal medicine residents and fellows. |
| dual antiplatelet therapy after pci guidelines: Oncologic Critical Care Joseph L. Nates, Kristen J. Price, 2019-10-30 This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients. |
| dual antiplatelet therapy after pci guidelines: Cardiac Intensive Care - E-Book David L. Brown, 2018-07-19 Using a multidisciplinary, team-oriented approach, this unique title expertly covers all the latest approaches to the assessment, diagnosis, and treatment of patients with critical cardiac illness. Led by Dr David L. Brown, a stellar team of authoritative writers guides you through cardiac pathophysiology, disease states presenting in the CICU, and state-of-the-art advanced diagnosis and therapeutic techniques. A visually appealing format, new chapters, and thorough updates ensure that you stay on the cutting edge of this rapidly advancing field. - Discusses recent changes in cardiac intensive care, including new care paradigms, new mechanical support modalities, and new therapies and interventions. - Contains 11 new chapters: Palliative Care, Temporary Pacemaker Insertion, Pericardiocentesis, Distributive Shock, Electrical Storm, Cardiopulmonary Cerebral Resuscitation after Cardiac Arrest, Temporary Mechanical Circulatory Support Devices, Cardiorenal Syndrome, Fulminant Myocarditis, Stress-Induced Cardiomyopathy, Diagnosis and Treatment of Unstable Supraventricular Tachycardia. - Online access features heart sounds and murmurs to accompany the chapter on history and physical examination, videos of clinical images and key procedures, frequently updated information on late-breaking clinical trials, reviews of new research publications, and more. - Concisely yet thoroughly covers acute and severe heart failure, chronic pulmonary hypertension, life-threatening dysrhythmias, aortic dissection, and other cardiac conditions as they relate to intensive care. - Explains drug therapy for key cardiac drugs, such as inotropes, vasodilators, anti-arrhythmics, diuretics, anticoagulants, and anti-platelets, and discusses important drug interactions. - Ideal for all healthcare professionals involved in cardiac intensive care, including intensivists, cardiologists, cardiac surgeons, residents, fellows, cardiac nurses, respiratory therapists, physical therapists, and nutritionists. - Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices and contains an up to date collection of all relevant ACC/AHA and ESC guidelines. |
| dual antiplatelet therapy after pci guidelines: Cardiology Secrets Glenn N. Levine, 2014 Get quick answers to the most important clinical questions with Cardiology Secrets! Using the popular and trusted Secret Series(R) Q&A format, this easy-to-read cardiology book provides rapid access to the practical, in-the-trenches know-how you need to succeed both in practice, and on cardiology board and recertification exams. Get the evidence-based guidance you need to provide optimal care for your patients with cardiac heart diseases. Explore effective solutions to a full range of clinical issues including the general examination, diagnostic procedures, arrhythmias, symptoms and disease states, valvular heart disease, cardiovascular pharmacology, and other medical conditions with associated cardiac involvement. Zero in on key information with bulleted lists, mnemonics, practical tips from the leading cardiologists, and Key Points boxes that provide a concise overview of important board-relevant content. Review essential material efficiently with the Top 100 Secrets in Cardiology - perfect for last-minute study or self-assessment. Apply all the latest advances in clinical cardiology techniques, technology, and pharmacology. Access the complete text and illustrations online at Expert Consult, fully searchable. |
| dual antiplatelet therapy after pci guidelines: Biomaterials and Devices for the Circulatory System Terence Gourlay, Richard A Black, 2016-08-19 Cardiovascular disease is one of the leading causes of death in the world today. Thanks to major advances in circulatory biomaterials and medical devices over the past few decades, many complications of this prevalent disease can be managed with great success for prolonged periods. Biomaterials and devices for the circulatory system reviews the latest developments in this important field and how they can be used to improve the success and safety in this industry. Part one discusses physiological responses to biomaterials with chapters on tissue response, blood interface and biocompatibility. Part two then reviews clinical applications including developments in valve technology, percutaneous valve replacement, bypass technologies and cardiovascular stents. Part three covers future developments in the field with topics such as nanomedicine, cardiac restoration therapy, biosensor technology in the treatment of cardiovascular disease and vascular tissue engineering. With its distinguished editors and international team of contributors Biomaterials and devices for the circulatory system is a vital reference for those concerned with bioengineering, medical devices and clinicians within this critical field. |
| dual antiplatelet therapy after pci guidelines: Atrial Fibrillation National Collaborating Centre for Chronic Conditions (Great Britain), 2006 |
| dual antiplatelet therapy after pci guidelines: Anticoagulation Therapy Ozcan Basaran, Murat Biteker, 2016-09-08 The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists. |
| dual antiplatelet therapy after pci guidelines: Cardiovascular Pharmacogenetics Martin R. Wilkins, 2003-12-02 The Human Genome Project was sold to the general public largely on the basis that a complete picture of the structure of human DNA would lead to new and better medicines. These medicines would be better because they would be tailored to individual patients, maximising the chances of a therapeutic response and mi nimising the risks of an adverse event. Taking the idea further, pundits have pre dicted that the time will come when we could carry our DNA on a card which could be read rapidly and enable the physician to choose the best drug. This is the future. This is pharmacogenetics. When the draft human DNA sequence was announced and scientists were as ked how this would help drug development, the example most frequently given was the debrisoquine model - where poor metabolisers of this hypotensive agent are exposed to higher plasma levels from a standard dose and at risk of collapse from excessive hypotension. This observation was made over 20 years ago and predated designs to sequence the human genome. Nonetheless, it raised aware ness of variation in drug metabolism and was correctly assigned to genetic poly morphisms affecting CYP2D6. Together with the discovery of pseudocholinestera se deficiency, it marked the birth of pharmacogenetics. The debrisoquine example is an interesting one and worthy of further analysis. |
| dual antiplatelet therapy after pci guidelines: Controversies in Cardiology John A. Ambrose, Alfredo E. Rodríguez, 2015-09-10 This book will consider several clinical and interventional topics for which there is uncertainty, continued debate and/or no consensus based on current guidelines. While there are numerous guidelines in cardiology, new and on-going trials that address new drugs treatments and procedures raise many unanswered questions. Furthermore, most practicing cardiologist taking care of the patients are likely unable to digest all of these studies or guidelines and necessarily correctly apply them to their patients. If one considers in the guidelines the frequent use of Level C (consensus), there are many areas or situations where no trial exists. Also, when applying the results of a trial to an individual patient, there can be uncertainty of how this patient should be managed based on the present body of evidence. |
| dual antiplatelet therapy after pci guidelines: The ESC Textbook of Cardiovascular Medicine A. John Camm, 2019 |
| dual antiplatelet therapy after pci guidelines: Primary and Secondary Angina Pectoris European Society of Cardiology, 1978 |
| dual antiplatelet therapy after pci guidelines: Current Clinical Practice Franz H. Messerli, 1987 Focuses on the therapeutic management of medical disorders as practiced by 13 of the leading private clinics in the U.S.--Cleveland, Geisinger, Guthrie, Henry Ford, Joslin, Lahey, Lovelace-Bataan, Marshfield, Mayo, Ochsner, Palo Alto, Scripps, and Scott & White. Provides clear, practical guidelines on how specific disorders are managed. Emphasizes outpatient management and treatment of adults. Presents concise and detailed aspects of drug and non-drug treatment, allowing the reader to select the therapeutic regimen most appropriate for a specific situations. Shows how high-standard medicine is practiced on a day-to-day and cost-effective basis. |
| dual antiplatelet therapy after pci guidelines: Coronary Lesions Patrick W. Serruys, Martin B. Leon, Antonio Colombo, Michael J B Kutryk, 2001-09-13 The interventional cardiologist has to tackle a diverse and complex range of coronary lesions. For this reason, the experts who compiled this volume contribute the best practices for overcoming plaque and thrombus in the coronary arteries. From simple to complicated anatomy, the direct approach to achieving optimal results is clearly described and illustrated. Each chapter focuses on a specific problem, and top quality angiograms illustrate the various coronary lesions. The editors, all experts and pioneers in the field of interventional cardiology, from stenting to myocardial revascularization, have assembled a team of internationally renowned contributors to offer their practical advice on how to approach lesions in a straight-forward, pragmatic fashion. This guide is indispensable for cardiologists and students of the field, as well as for general practitioners. |
| dual antiplatelet therapy after pci guidelines: Manual of Coronary Chronic Total Occlusion Interventions Emmanouil S. Brilakis, 2023 |
| dual antiplatelet therapy after pci guidelines: Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease Sorin Brener, 2021-01-09 Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to understand platelet physiology and its relevance to ischemic events. Data on shorter than usual duration of DAPT, and on extended therapy beyond the recommendation of current guidelines is presented in great detail, summarizing a large body of evidence into concrete, relevant recommendation that is readily adaptable by practicing clinicians. A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years. - Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians - Explores the current status of DAPT, controversial topics, and future developments and trends in this field - Edited and contributed by renowned cardiologists in the field |
| dual antiplatelet therapy after pci guidelines: Antiplatelet and Anticoagulation Therapy In PCI, An Issue of Interventional Cardiology Clinics Dominick J. Angiolillo, Matthew J. Price, 2016-11-26 This issue of Interventional Cardiology Clinics, edited by Drs. Dominick Angiolillo and Matthew Price, will focus on Antiplatelet and Anticoagulation Therapy in PCI. The topics covered in this volume will span across pretreatment with antiplatelet agents; optimal duration of antiplatelet therapy after PCI; Cangrelor and its role in percutaneous coronary intervention; Ticagrelor and its effects beyond the P2Y12 receptor; dyspnea and Reversibly-binding P2Y12 antagonists; PAR receptor inhibition post-PCI; switching P2Y12 receptor inhibiting therapies; antiplatelet and antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting; antithrombotic therapy to reduce ischemic events in ACS patients undergoing PCI; and the current role of platelet function testing in PCI and CABG, among other topics. |
| dual antiplatelet therapy after pci guidelines: Cardiology Update 2022 Vijay Bang, Ashish Deshpande, Vigyan Bang, 2022-11-28 |
| dual antiplatelet therapy after pci guidelines: Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America Alexander Fanaroff, John W. Hirshfeld Jr, 2024-03-28 In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease. - Contains 13 relevant, practice-oriented topics including optimal medical therapy for stable ischemic heart disease in 2024: focus on antithrombotic therapy; antiplatelet therapy for patients that have undergone revascularization within the past year: which agents and for how long; ischemic heart disease in women: focus on SCAD and MINOCA; and more. - Provides in-depth clinical reviews on patient management with stable ischemic heart disease, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. |
| dual antiplatelet therapy after pci guidelines: Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, An Issue of Interventional Cardiology Clinics Luis Ortega Paz, 2024-09-12 In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more. - Contains 13 relevant, practice-oriented topics including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more. - Provides in-depth clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. |
| dual antiplatelet therapy after pci guidelines: Coronary Care Manual Peter L. Thompson, 2010-12-03 The Coronary Care Manual has been designed as a practical manual for the management of the acute coronary patient, and aims to achieve a balance between the large and rapidly changing evidence base and practical application in the CCU, ICU, ED and ambulance. The book has been written by a group of Australian and international experts for medical, nursing and paramedic staff working in these areas. This edition covers a broad range of coronary care medicine in enough detail to eliminate the need to refer to a larger reference book, providing a portable companion for a night on call. Completely redesigned with new artwork, the manual is organized to suit academics and practitioners alike. • covers a broad range of coronary care medicine• provides specific advice on the management of common clinical problems• eliminates the need to refer to a larger reference book• features a consistent style and focus, with standardised artwork for figures• is now also available as an eBook! A code inside the Coronary Care Manual enables a full text download, allowing you to browse and search electronically, make notes and bookmarks in the electronic files and highlight material |
Marvel Rivals Console/Controller Settings Guide 2025
Dec 27, 2024 · Aim Response Curve Type: Determines how your controller responds when you tilt your right analog stick. You have a choice between Dual-Zone (the new default Overwatch …
Best armour and augments for Dual Guns + Longsword build
Apr 18, 2025 · Tc did specifically mention blossom dance. And resistances aren't important when using ghost walker/factory, which I assume he is given the dual guns. Yup I want to abuse …
Conditions for Dual Ultimates? - Dragon Ball: Xenoverse 2
As long as the custom partner has the Dual Ultimate equipped, they will use it every so often and then you can do the input for the second part of the attack no matter what you have equipped. …
Can I dual wield? - The Elder Scrolls IV: Oblivion - GameFAQs
Sep 10, 2007 · At stage 25 of The Path of Dawn quest, it is scripted for no apparent reason for Martin Septim to have a Lesser Staff of Lightning removed from his inventory, even though, …
Character Creation - Icewind Dale: Enhanced Edition
Apr 30, 2021 · For two-class combinations, dual-classing from Fighter is slightly better than multiclassing because dual-classing gives Grand Mastery, more HP and faster level gain. …
Resident Evil: Director's Cut Walkthrough & Guide - GameFAQs
Mar 24, 2024 · The Director's Cut is the first version of the original Resident Evil that I had played and the one I like best. While the Dual Shock edition that followed adds functionality to the …
Differences between original and Dual Shock versions?
My bad, in regards to the Ink Ribbons... to be really specific, in both modes of the original Director's Cut and in Arrange Mode in the Dual Shock version, you get 3 ribbons each pickup. …
Character Creation - Baldur's Gate: Enhanced Edition
Apr 21, 2024 · Multiclass vs. Dual Class There is a subtle distinction between multiclass characters and dual-class characters. The idea of playing an A / B multiclass character (for …
Ideal build for Rush for the first playthrough
For me I'm just going for a dual-wield build. Probably a ninja if I can get the requirements for it down. I was BR25 at The Fallen on PC and I got Rush to Ninja about halfway through. Now …
Some suggestions after 20+ hours for those still struggling
Oct 26, 2024 · Dual Gunner (Tech): fire-infused attack; Quadrastrike (Tech): high-BP damage (perfect for United Attack) Heeled Sandals (Legs): allows you to use a special kick attack …
Marvel Rivals Console/Controller Settings Guide 2025
Dec 27, 2024 · Aim Response Curve Type: Determines how your controller responds when you tilt your right analog stick. You have a choice between Dual-Zone (the new default Overwatch …
Best armour and augments for Dual Guns + Longsword build
Apr 18, 2025 · Tc did specifically mention blossom dance. And resistances aren't important when using ghost walker/factory, which I assume he is given the dual guns. Yup I want to abuse …
Conditions for Dual Ultimates? - Dragon Ball: Xenoverse 2
As long as the custom partner has the Dual Ultimate equipped, they will use it every so often and then you can do the input for the second part of the attack no matter what you have equipped. …
Can I dual wield? - The Elder Scrolls IV: Oblivion - GameFAQs
Sep 10, 2007 · At stage 25 of The Path of Dawn quest, it is scripted for no apparent reason for Martin Septim to have a Lesser Staff of Lightning removed from his inventory, even though, …
Character Creation - Icewind Dale: Enhanced Edition
Apr 30, 2021 · For two-class combinations, dual-classing from Fighter is slightly better than multiclassing because dual-classing gives Grand Mastery, more HP and faster level gain. …
Resident Evil: Director's Cut Walkthrough & Guide - GameFAQs
Mar 24, 2024 · The Director's Cut is the first version of the original Resident Evil that I had played and the one I like best. While the Dual Shock edition that followed adds functionality to the …
Differences between original and Dual Shock versions?
My bad, in regards to the Ink Ribbons... to be really specific, in both modes of the original Director's Cut and in Arrange Mode in the Dual Shock version, you get 3 ribbons each pickup. …
Character Creation - Baldur's Gate: Enhanced Edition
Apr 21, 2024 · Multiclass vs. Dual Class There is a subtle distinction between multiclass characters and dual-class characters. The idea of playing an A / B multiclass character (for …
Ideal build for Rush for the first playthrough
For me I'm just going for a dual-wield build. Probably a ninja if I can get the requirements for it down. I was BR25 at The Fallen on PC and I got Rush to Ninja about halfway through. Now …
Some suggestions after 20+ hours for those still struggling
Oct 26, 2024 · Dual Gunner (Tech): fire-infused attack; Quadrastrike (Tech): high-BP damage (perfect for United Attack) Heeled Sandals (Legs): allows you to use a special kick attack …
